JYLAMVO (methotrexate)


Drug overview for JYLAMVO (methotrexate):

Generic name: methotrexate (METH-oh-TREX-ate)
Drug class: Antipsoriatics
Therapeutic class: Antineoplastics

Methotrexate, a folic acid antagonist, is an antineoplastic agent and immunosuppressant.

No enhanced Uses information available for this drug.
DRUG IMAGES
  • No Image Available
    No Image Available
The following indications for JYLAMVO (methotrexate) have been approved by the FDA:

Indications:
Acute lymphoid leukemia
Mycosis fungoides
Non-Hodgkin's lymphoma
Polyarticular juvenile idiopathic arthritis
Rheumatoid arthritis
Severe recalcitrant psoriasis


Professional Synonyms:
Acute lymphatic leukemia
Acute lymphocytic leukemia
Acute lymphogenous leukemia
Arthritis deformans
Arthrosis deformans
Lymphoblastic leukemia
Nodose rheumatism
Non-Hodgkin's type lymphoma
Polyarticular JIA
Polyarticular JRA
Polyarticular juvenile chronic arthritis
Polyarticular juvenile rheumatoid arthritis
Rheumatic arthritis
Rheumatic gout
Severe intractable psoriasis
Severe refractory psoriasis